Emcure Pharmaceuticals (India) Buy Hold or Sell Recommendation
| EMCURE Stock | 1,373 16.15 1.16% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Emcure Pharmaceuticals is 'Cautious Hold'. Macroaxis provides Emcure Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EMCURE positions.
Check out Emcure Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Emcure and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Emcure Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Emcure |
Execute Emcure Pharmaceuticals Buy or Sell Advice
The Emcure recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Emcure Pharmaceuticals. Macroaxis does not own or have any residual interests in Emcure Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Emcure Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Emcure Pharmaceuticals Trading Alerts and Improvement Suggestions
| Emcure Pharmaceuticals generated a negative expected return over the last 90 days | |
| About 87.0% of the company shares are held by company insiders |
Emcure Pharmaceuticals Returns Distribution Density
The distribution of Emcure Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Emcure Pharmaceuticals' future price movements. The chart of the probability distribution of Emcure Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Emcure Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Emcure Pharmaceuticals returns is essential to provide solid investment advice for Emcure Pharmaceuticals.
| Mean Return | -0.14 | Value At Risk | -4.02 | Potential Upside | 3.60 | Standard Deviation | 2.28 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Emcure Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Emcure Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Emcure Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Emcure Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Emcure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 0.65 | |
σ | Overall volatility | 2.25 | |
Ir | Information ratio | -0.07 |
Emcure Pharmaceuticals Volatility Alert
Emcure Pharmaceuticals exhibits very low volatility with skewness of 0.08 and kurtosis of 1.46. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Emcure Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Emcure Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Emcure Pharmaceuticals Fundamentals Vs Peers
Comparing Emcure Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Emcure Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Emcure Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Emcure Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Emcure Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Emcure Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Emcure Pharmaceuticals to competition |
| Fundamentals | Emcure Pharmaceuticals | Peer Average |
| Profit Margin | 0.07 % | (1.27) % |
| Operating Margin | 0.13 % | (5.51) % |
| Current Valuation | 295.8 B | 16.62 B |
| Shares Owned By Insiders | 86.77 % | 10.09 % |
| Shares Owned By Institutions | 3.53 % | 39.21 % |
| Price To Book | 9.39 X | 9.51 X |
| Price To Sales | 3.92 X | 11.42 X |
| Revenue | 69.17 B | 9.43 B |
| EBITDA | 12.05 B | 3.9 B |
| Book Value Per Share | 162.97 X | 1.93 K |
| Earnings Per Share | 26.38 X | 3.12 X |
| Target Price | 1575.0 | |
| Market Capitalization | 270.98 B | 19.03 B |
Emcure Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Emcure . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0289 | |||
| Daily Balance Of Power | (0.40) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1365.0 | |||
| Day Typical Price | 1367.63 | |||
| Market Facilitation Index | 40.0 | |||
| Price Action Indicator | (0.17) | |||
| Period Momentum Indicator | (16.15) |
About Emcure Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Emcure Pharmaceuticals? Buying financial instruments such as Emcure Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Emcure Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Farming Thematic Idea Now
Farming
Companies producing farming products and providing services for farmers. The Farming theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Emcure Stock
Emcure Pharmaceuticals financial ratios help investors to determine whether Emcure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emcure with respect to the benefits of owning Emcure Pharmaceuticals security.